Core Capabilities
-
Manufacturer of solid dosage forms
-
Extensive primary and secondary packaging capacity
-
Special expertise in formulating highly potent products
-
Full range of services including API purification, formulation development, clinical trial supply and pharma-logistics
CordenPharma Plankstadt Facility Capacities
Compliance Approvals
-
EMEA - 2007
-
FDA – 2009
-
ANVISA - 2009
-
German Authorities – 2011
Facility Legacy
Corden Pharma GmbH is an expert manufacturer of solid dosage forms with special expertise in API purification, formulation of highly potent products and a full range of services from pharmaceutical manufacturing to packaging and pharma-logistics (CEE-hub).
As a former operations site of AstraZeneca, CordenPharma Plankstadt brings expertise and extensive capabilities with two facilities for the formulation of solid dosage products, a standard facility for the formulation of high-volume non-potent tablets and capsules and a containment facility designed for the manufacturing of non-cytotoxic hormones and hormone blockers.
History
-
1970 Rhein-Pharma (Imperial Chemical Industries / Rhein-Chemie) sets up a new production site at Plankstadt
-
Start-up of packing facility
-
1978 Production is expanded by a new active substance purification facility
-
Start-up of formulation facility
-
1983 Expansion of the laboratory capacities
-
2002 Start-up of the high-containment tablet production facility
-
2007/2008 former AstraZeneca Plankstadt plant acquired by ICIG to become CordenPharma Plankstadt GmbH
-
2009 Latest FDA Audit